TIAA CREF Investment Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $2.29M | Buy |
773,231
+516,702
| +201% | +$1.53M | ﹤0.01% | 1933 |
|
2018
Q4 | $408K | Sell |
256,529
-27,161
| -10% | -$43.2K | ﹤0.01% | 2653 |
|
2018
Q3 | $1.04M | Sell |
283,690
-338,170
| -54% | -$1.24M | ﹤0.01% | 2402 |
|
2018
Q2 | $1.76M | Sell |
621,860
-174,529
| -22% | -$494K | ﹤0.01% | 2236 |
|
2018
Q1 | $2.96M | Buy |
796,389
+432,818
| +119% | +$1.61M | ﹤0.01% | 1882 |
|
2017
Q4 | $1.05M | Buy |
363,571
+42,358
| +13% | +$122K | ﹤0.01% | 2442 |
|
2017
Q3 | $1.44M | Sell |
321,213
-107,720
| -25% | -$484K | ﹤0.01% | 2336 |
|
2017
Q2 | $1.97M | Buy |
428,933
+21,183
| +5% | +$97.2K | ﹤0.01% | 2187 |
|
2017
Q1 | $1.72M | Buy |
407,750
+10,558
| +3% | +$44.5K | ﹤0.01% | 2224 |
|
2016
Q4 | $1.64M | Sell |
397,192
-102,636
| -21% | -$424K | ﹤0.01% | 2288 |
|
2016
Q3 | $4.05K | Buy |
499,828
+17,316
| +4% | +$140 | ﹤0.01% | 1744 |
|
2016
Q2 | $3.76M | Sell |
482,512
-42,479
| -8% | -$331K | ﹤0.01% | 1742 |
|
2016
Q1 | $4.05M | Sell |
524,991
-54,928
| -9% | -$424K | ﹤0.01% | 1643 |
|
2015
Q4 | $6.26M | Buy |
579,919
+101,814
| +21% | +$1.1M | ﹤0.01% | 1388 |
|
2015
Q3 | $3.3M | Sell |
478,105
-43,323
| -8% | -$299K | ﹤0.01% | 1837 |
|
2015
Q2 | $4.62M | Buy |
521,428
+41,421
| +9% | +$367K | ﹤0.01% | 1741 |
|
2015
Q1 | $4.73M | Buy |
480,007
+48,226
| +11% | +$476K | ﹤0.01% | 1678 |
|
2014
Q4 | $5.29M | Sell |
431,781
-20,052
| -4% | -$246K | ﹤0.01% | 1590 |
|
2014
Q3 | $4.51M | Buy |
451,833
+8,338
| +2% | +$83.2K | ﹤0.01% | 1682 |
|
2014
Q2 | $3.36M | Buy |
443,495
+37,541
| +9% | +$284K | ﹤0.01% | 1963 |
|
2014
Q1 | $1.34M | Sell |
405,954
-9,530
| -2% | -$31.4K | ﹤0.01% | 2474 |
|
2013
Q4 | $1.38M | Buy |
415,484
+29,500
| +8% | +$97.9K | ﹤0.01% | 2479 |
|
2013
Q3 | $1.17M | Sell |
385,984
-15,519
| -4% | -$46.9K | ﹤0.01% | 2530 |
|
2013
Q2 | $3.28M | Buy |
+401,503
| New | +$3.28M | ﹤0.01% | 1827 |
|